World's 1st enzymatic technology to produce β-NMN
In 2014, Bontac took the lead in realizing the industrialization of NMN
In 2021, Bontac achieve the world's first massive production of NMNH

NMR, HRMS data to confirm the genuine of β-NMN
More than 40 high-precision imported testing equipment and dozens of testing indicators

Supplier of the first human clinical trial of β-NMN
Conform to the national acute oral toxicity test

Joint Research Centre with numerous internationally well-known universities
β-NMN of 30+ global research institutions

Obtained more than 10 NMN related patents at home and abroad
Hundreds of independently developed enzyme catalysis-related invention patents and international patent applications

Always adhere to the whole-enzyme catalytic production, stable quality, high safety
Upgrade of coenzyme production line 3rd generation enzyme catalysis technology was implemented, Coenzyme production expand to annual output of 100 tons